Mar 24, 2026 You have probably heard that tirzepatide causes headaches
GLP1-Ras are incretin-based glucose-lowering medications that are commonly used to treat type 2 diabetes and obesity
View on Amazon LMNT Recharge Electrolyte Drink Mix Electrolyte mix paired with GLP-1 protocols where appetite suppression reduces fluid + sodium intake
EMA Decision P/0336/2024 Retatrutide Paediatric Investigation Plan (confirming no marketing authorisation)
- Tolerability profile consistent with the incretin class, with gastrointestinal events most commonly reported in studies (e.g., nausea, diarrhoea, and constipation)
Additionally, GLP-1 promotes feelings of fullness, which can lead to a decrease in caloric intake and potential weight loss